Lurbinectedin

Am J Health Syst Pharm. 2020 Oct 30;77(22):1815-1817. doi: 10.1093/ajhp/zxaa278.
No abstract available

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Carbolines / pharmacology*
  • Carbolines / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Interactions
  • Drug Labeling*
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Heterocyclic Compounds, 4 or More Rings / therapeutic use
  • Humans
  • Infusions, Intravenous
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Small Cell Lung Carcinoma / drug therapy*
  • Small Cell Lung Carcinoma / secondary

Substances

  • Antineoplastic Agents
  • Carbolines
  • Heterocyclic Compounds, 4 or More Rings
  • PM 01183